Table 3. Non-linear OLS models.

	(1)	(2)	(3)	(4)	(5)	(6)
	Cost per woman tested (ln)	Cost per woman tested (ln)	Cost per woman tested (ln)	Cost per woman in ART (ln)	Cost per woman in ART (ln)	Cost per woman in ART (ln)
VARIABLES
Supply side characteristics
Scale (ln)	-0.58***	-0.42	3.19***	-0.72***	-1.05***	0.19
	(0.07)	(0.46)	(0.76)	(0.07)	(0.37)	(0.64)
Scale squared (ln)		-0.01	-0.72***		0.06	-0.42*
		(0.04)	(0.13)		(0.06)	(0.23)
Scale cubic (ln)			0.04***			0.055**
			(0.007)			(0.02)
Hospital (0,1)	0.39**	0.40**	0.35*	0.33*	0.29	0.23
	(0.18)	(0.18)	(0.17)	(0.18)	(0.18)	(0.18)
Primary care nurse (%)	-0.36	-0.37	-0.32	-0.34	-0.25	-0.31
	(0.23)	(0.23)	(0.22)	(0.27)	(0.30)	(0.31)
Urban area	0.45	0.50	0.16	1.26**	1.00**	0.68*
	(0.34)	(0.33)	(0.27)	(0.48)	(0.46)	(0.40)
Demand side characteristics
Maternal HIV prevalence	0.009	0.01	0.01	0.001	-0.001	-0.001
	(0.007)	(0.007)	(0.007)	(0.008)	(0.008)	(0.008)
MTCT, 9–18 months	-0.04	-0.03	-0.12***	0.01	-0.03	-0.09
	(0.05)	(0.05)	(0.04)	(0.08)	(0.08)	(0.07)
HIV-free infant survival, 9–18 months	-0.05	-0.04	-0.12***	0.009	-0.03	-0.09
	(0.05)	(0.05)	(0.03)	(0.08)	(0.08)	(0.07)
Uptake of HIV testing during pregnancy	0.008	0.008	0.008	0.001	0.002	0.002
	(0.007)	(0.007)	(0.006)	(0.008)	(0.008)	(0.007)
Process quality
Offers contraception services	-0.001	0.001	0.007	-0.02	-0.02	-0.03
	(0.04)	(0.04)	(0.04)	(0.05)	(0.05)	(0.05)
Offers ARV prophylaxis	0.007	0.001	-0.06	0.16	0.15	0.13
	(0.10)	(0.10)	(0.09)	(0.14)	(0.14)	(0.14)
Offers ANC services	0.009	0.012	0.02	0.003	-0.003	-0.004
	(0.03)	(0.03)	(0.03)	(0.04)	(0.04)	(0.04)
Constant	11.38*	10.21*	12.40***	6.40	11.64	17.20**
	(5.88)	(5.89)	(4.45)	(8.54)	(9.09)	(8.11)
Observations	130	130	130	122	122	122
R-squared	0.49	0.48	0.53	0.46	0.46	0.48

Robust standard errors in parentheses

*** p<0.01,

** p<0.05,

* p<0.1